These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33740173)

  • 1. Exercise Participation for Patients with Valvular Heart Disease: a Review of the Current Guidelines.
    Fernandez AB; Thompson PD
    Curr Cardiol Rep; 2021 Mar; 23(5):49. PubMed ID: 33740173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey.
    Iung B; Delgado V; Rosenhek R; Price S; Prendergast B; Wendler O; De Bonis M; Tribouilloy C; Evangelista A; Bogachev-Prokophiev A; Apor A; Ince H; Laroche C; Popescu BA; Piérard L; Haude M; Hindricks G; Ruschitzka F; Windecker S; Bax JJ; Maggioni A; Vahanian A;
    Circulation; 2019 Oct; 140(14):1156-1169. PubMed ID: 31510787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Athletes with valvular heart disease and competitive sports: a position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology.
    van Buuren F; Gati S; Sharma S; Papadakis M; Adami PE; Niebauer J; Pelliccia A; Rudolph V; Börjesson M; Carre F; Solberg E; Heidbuchel H; Caselli S; Corrado D; Serratosa L; Biffi A; Pressler A; Schmied C; Panhuyzen-Goedkoop NM; Rasmussen HK; La Gerche A; Faber L; Bogunovic N; D'Ascenzi F; Mellwig KP
    Eur J Prev Cardiol; 2021 Dec; 28(14):1569-1578. PubMed ID: 33846742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exercise recommendations in patients with valvular heart disease.
    Gati S; Malhotra A; Sharma S
    Heart; 2019 Jan; 105(2):106-110. PubMed ID: 30262455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical activity and exercise recommendations for patients with valvular heart disease.
    Chatrath N; Papadakis M
    Heart; 2022 Nov; 108(24):1938-1944. PubMed ID: 35236765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
    Lip GYH; Collet JP; Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B;
    Europace; 2017 Nov; 19(11):1757-1758. PubMed ID: 29096024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise testing and stress imaging in valvular heart disease.
    Henri C; Piérard LA; Lancellotti P; Mongeon FP; Pibarot P; Basmadjian AJ
    Can J Cardiol; 2014 Sep; 30(9):1012-26. PubMed ID: 25151284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommendations for the management of individuals with acquired valvular heart diseases who are involved in leisure-time physical activities or competitive sports.
    Mellwig KP; van Buuren F; Gohlke-Baerwolf C; Bjørnstad HH
    Eur J Cardiovasc Prev Rehabil; 2008 Feb; 15(1):95-103. PubMed ID: 18277193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease.
    Iung B; Baron G; Butchart EG; Delahaye F; Gohlke-Bärwolf C; Levang OW; Tornos P; Vanoverschelde JL; Vermeer F; Boersma E; Ravaud P; Vahanian A
    Eur Heart J; 2003 Jul; 24(13):1231-43. PubMed ID: 12831818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valvular heart disease in Japan: Characteristics and treatment of patients in acute care hospitals in 2019.
    Izumi C; Matsuyama R; Asaoka M; Iwasaki K; Takeshima T; Murphy S; Teng L; Igarashi A
    J Cardiol; 2023 Jul; 82(1):29-34. PubMed ID: 36963659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution, Characteristics, and Management of Older Patients With Valvular Heart Disease in China: China-DVD Study.
    Xu H; Liu Q; Cao K; Ye Y; Zhang B; Li Z; Hao J; Qi X; Zhao Q; Liu S; Gao R; Wu Y;
    JACC Asia; 2022 Jun; 2(3):354-365. PubMed ID: 36338396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, Characteristics, and Outcomes of Valvular Heart Disease in Patients With Atrial Fibrillation: Insights From the ORBIT-AF (Outcomes Registry for Better Informed Treatment for Atrial Fibrillation).
    Thomas KL; Jackson LR; Shrader P; Ansell J; Fonarow GC; Gersh B; Kowey PR; Mahaffey KW; Singer DE; Thomas L; Piccini JP; Peterson ED
    J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29273635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the Recent Updates to the ACC/AHA and ESC Guidelines for the Management of Valvular Heart Disease: Similarities and Differences.
    Laskar N; Badiani S; Treibel T; Bhattacharyya S; Lloyd G
    Curr Cardiol Rep; 2023 Mar; 25(3):147-156. PubMed ID: 36708504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Nursing Management for Valvular Disease.
    Lee S
    Crit Care Nurs Clin North Am; 2019 Mar; 31(1):31-38. PubMed ID: 30736933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exercise in valvular heart disease: risks and benefits.
    Parker MW; Thompson PD
    Prog Cardiovasc Dis; 2011; 53(6):437-46. PubMed ID: 21545930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Year in Cardiology 2013: valvular heart disease (focus on catheter-based interventions).
    Grube E; Sinning JM; Vahanian A
    Eur Heart J; 2014 Feb; 35(8):490-5. PubMed ID: 24385378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary Hypertension with Valvular Heart Disease: When to Treat the Valve Disease and When to Treat the Pulmonary Hypertension.
    Martinez C; Tsugu T; Sugimoto T; Lancellotti P
    Curr Cardiol Rep; 2019 Nov; 21(12):151. PubMed ID: 31768665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Priorities for Patient-Centered Research in Valvular Heart Disease: A Report From the National Heart, Lung, and Blood Institute Working Group.
    Lindman BR; Arnold SV; Bagur R; Clarke L; Coylewright M; Evans F; Hung J; Lauck SB; Peschin S; Sachdev V; Tate LM; Wasfy JH; Otto CM
    J Am Heart Assoc; 2020 May; 9(9):e015975. PubMed ID: 32326818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
    Nishimura RA; Otto CM; Bonow RO; Carabello BA; Erwin JP; Guyton RA; O'Gara PT; Ruiz CE; Skubas NJ; Sorajja P; Sundt TM; Thomas JD;
    J Am Coll Cardiol; 2014 Jun; 63(22):e57-185. PubMed ID: 24603191
    [No Abstract]   [Full Text] [Related]  

  • 20. Valvular Heart Disease in Athletes.
    Petek BJ; Baggish AL
    Curr Treat Options Cardiovasc Med; 2021; 23(11):. PubMed ID: 35356384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.